Enhanced therapeutic effect on androgen-independent prostate cancer by depsipeptide (FK228), a histone deacetylase inhibitor, in combination with docetaxel.

Zhang, Zhengwang

Enhanced therapeutic effect on androgen-independent prostate cancer by depsipeptide (FK228), a histone deacetylase inhibitor, in combination with docetaxel. [electronic resource] - Urology Aug 2007 - 396-401 p. digital

Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.

1527-9995

10.1016/j.urology.2007.03.052 doi


Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Depsipeptides--administration & dosage
Docetaxel
Humans
Male
Prostatic Neoplasms--drug therapy
Taxoids--administration & dosage
Tumor Cells, Cultured